Morning Rounds · Gynaecology Series
Gynaecology
A Guide to the Morning Rounds Series
A Guide to the Morning Rounds Series
Seven high-yield rounds · 35 clinical cases · NEET-PG / INI-CET / UPSC CMS · +4 / −1 scoring
Gynaecology asks a different kind of discriminating question than obstetrics does: not which legal threshold has been crossed, but which classification a presentation actually belongs to, and whether the feature in front of you is the genuine diagnostic anchor or a plausible-sounding distractor built to feel like one. A disproportionate share of high-yield gynaecology MCQs sit precisely at that point — the criterion that is actually required for a diagnosis, against the one that merely sounds like it should be.
That shapes every case in this series. The PCOS question is not just about hirsutism and irregular cycles; it is about whether the Rotterdam criteria's any-two-of-three structure has actually been satisfied, and whether an LH:FSH ratio belongs in that calculation at all (it does not). The AUB question is not just about heavy bleeding; it is about where a fibroid's FIGO subtype sits relative to the endometrial cavity, since that location — not size — decides both the classification and the management. The postmenopausal bleeding question is barely a question at all: any bleeding gets worked up, with no threshold of lightness or self-resolution that earns an exception.
Gynaecology at these exams rewards those who know their classification systems cold, recognise the mechanism connecting seemingly unrelated risk factors, and refuse to let a single familiar-sounding feature stand in for the actual reasoning. The seven rounds below are built around those demands, with every option deliberately matched for length and confidence so that no answer is identifiable by its phrasing alone. Each round is five cases with full debrief panels. Take them in series or return to specific topics as revision requires.
The Seven Rounds
Round 01 · Gynaecology Series
Menstrual Physiology, Examination & Informed Consent
The series opener, and the discipline that carries through every round after it: distinguishing normal physiology from pathology rather than over-calling either. FIGO's normal-cycle parameters (frequency 24 to 38 days, duration up to 8 days, no intermenstrual or postcoital bleeding, no flooding) replace the textbook "28-day" figure as the actual diagnostic yardstick, with pad count treated as the subjective measure it is rather than an automatic trigger for workup. Mittelschmerz and physiologic leucorrhoea are worked through as textbook benign findings too often over-investigated, alongside the baseline gynaecological history and examination a first visit should routinely include — pelvic examination performed when indicated, not reflexively, with a chaperone offered as a matter of course rather than only on request. Informed consent for endometrial biopsy closes the procedural-consent thread, and the round ends on ASCUS with a positive high-risk HPV co-test: a screening abnormality that raises probability without itself being a diagnosis, triaged to colposcopy rather than reassurance or repeat cytology. One SVG diagram comparing screening against diagnostic testing in cervical pathology.
Round 02 · Gynaecology Series
Abnormal Uterine Bleeding & PALM-COEIN
Five cases built around the PALM-COEIN framework and the discipline of letting bleeding pattern, not assumption, drive the diagnosis. A submucosal fibroid case anchors the structural/non-structural split and the FIGO fibroid subclassification, where cavity-distorting (0–2) fibroids bleed disproportionately compared to intramural or subserosal disease of the same size. Anovulatory bleeding in a teenager is worked through as a mechanism question — an immature hypothalamic-pituitary-ovarian axis producing unopposed oestrogen, not excess progesterone, with a real long-term endometrial hyperplasia risk if the pattern persists. A second adolescent case turns on bleeding since menarche combined with bruising and epistaxis, the recognised trigger to screen for von Willebrand disease alongside, not after, the gynaecological workup. The round closes on AUB management itself: medical therapy first, with surgery reserved for failure rather than offered as a default.
Round 03 · Gynaecology Series
Polycystic Ovary Syndrome — Diagnosis & Management
Polycystic ovary syndrome reduced to the facts examiners actually test: the Rotterdam criteria's any-two-of-three structure, and the common misconception that an LH:FSH ratio or insulin resistance testing is required for diagnosis when neither is. The underlying mechanism — relatively elevated LH driving theca cell androgen synthesis, amplified by insulin resistance lowering hepatic SHBG and raising free androgen — is tested directly, including the specific trap of getting that SHBG direction backwards. A case of rapid-onset virilisation draws the line between PCOS and an androgen-secreting tumour or non-classic CAH, where tempo of onset, not severity alone, is the discriminator. The long-term endometrial hyperplasia risk from chronic anovulation is shown to apply regardless of fertility intentions, and the round closes on goal-directed management — letrozole when pregnancy is desired, a COCP when it is not, with metformin correctly placed as adjunct rather than first-line therapy.
Round 04 · Gynaecology Series
Endometriosis & Adenomyosis
Endometriosis and adenomyosis worked through as a diagnosis-mechanism-management arc. Laparoscopy with histological confirmation remains the definitive diagnostic standard even when an endometrioma is already visible on ultrasound, particularly for the peritoneal and superficial implants imaging cannot see. Adenomyosis is distinguished from leiomyoma on both clinical and MRI grounds — a symmetric, globular, tender uterus and thickened junctional zone against a fibroid's irregular enlargement and discrete, well-circumscribed masses. A deliberately counterintuitive case pairs minimal-stage disease with severe pain against extensive disease with minimal pain, the well-recognised discordance between ASRM stage and symptom severity. Infertility in minimal disease is traced to an inflammatory peritoneal environment rather than mechanical distortion, and the round closes on GnRH agonist therapy's hypoestrogenic bone-loss risk and the add-back therapy that mitigates it.
Round 05 · Gynaecology Series
Genital Tract Infections & Pelvic Inflammatory Disease
Genital tract infections and pelvic inflammatory disease, built around thresholds for action rather than waiting for confirmation. Trichomoniasis, bacterial vaginosis, and candidiasis are differentiated by wet-mount morphology rather than by pH, which overlaps between trichomoniasis and BV closely enough to mislead. The CDC's deliberately low minimum criteria for presumptive PID — cervical motion, uterine, or adnexal tenderness alone — are tested as a treat-now decision, not one that waits for culture or imaging given the reproductive stakes of delay. Fitz-Hugh-Curtis syndrome is worked through as a specifically named, capsular complication of PID rather than coincidental cholecystitis, and a tubo-ovarian abscess case turns the management decision on clinical response over 48 to 72 hours rather than on abscess size. The round closes on cumulative reproductive risk: each treated episode of PID still adds to lifetime tubal-factor infertility and ectopic pregnancy risk, a risk that does not plateau after the first episode.
Round 06 · Gynaecology Series
Menopause & Hormone Therapy
Menopause and hormone therapy, with the diagnosis itself treated as clinical rather than biochemical — twelve consecutive months of amenorrhea at the expected age, with FSH testing reserved for atypical presentations rather than routine confirmation, and a reminder that FSH fluctuates rather than rising smoothly through the transition. The thermoregulatory mechanism behind hot flushes — a narrowed hypothalamic thermoneutral zone, not a genuine rise in core temperature — is tested directly. The "window of opportunity" framing for HRT timing and cardiovascular risk anchors a case alongside the requirement for combined, not oestrogen-only, therapy in a woman with an intact uterus. A personal history of oestrogen receptor-positive breast cancer is worked through as a near-absolute contraindication that a progestin cannot neutralise, and the round closes on genitourinary syndrome of menopause, where low-dose local oestrogen occupies a meaningfully different risk category from systemic therapy.
Round 07 · Gynaecology Series
Gynaecological Malignancies
The series closer, covering the gynaecological malignancies most heavily weighted on these examinations. HPV typing is tested at its most commonly inverted point — 16 and 18 as the oncogenic drivers of cervical cancer, 6 and 11 as the low-risk types behind genital warts, not the reverse. Endometrial cancer risk factors are unified under a single mechanism, unopposed oestrogen, connecting obesity's peripheral aromatisation, nulliparity's fewer progesterone-dominant cycles, and PCOS's chronic anovulation. A screening case works through why no validated strategy, including CA-125 and ultrasound, reduces ovarian cancer mortality in average-risk women, and a staging case draws the line between cervical cancer's clinical staging and the surgical-pathological staging required for endometrial and ovarian disease. The round, and the series, close on the rule with zero exceptions: postmenopausal bleeding of any amount or duration is worked up before being attributed to atrophy.
Topics not covered in this series
This series covers the high-yield core of gynaecological practice for NEET-PG-level exams but is not encyclopaedic. Areas outside these seven rounds include: contraception and family planning, infertility workup and assisted reproduction beyond the endometriosis-specific mechanism covered here, uro-gynaecology — pelvic organ prolapse and urinary incontinence — vulval and vaginal disorders including lichen sclerosus and vulval malignancy, benign and malignant breast disease, and the surgical detail of hysterectomy and other gynaecological procedures themselves — each of which would warrant its own dedicated treatment. Obstetrics — antenatal care, labor and delivery, and obstetric law — is addressed as a separate, parallel Morning Rounds series.
A note for doctor-examinees
Gynaecology MCQs at NEET-PG reward the same instinct this series was built to train: recognising which classification a case belongs to before reaching for a diagnosis, and refusing to let a single feature — a recalled number, a familiar-sounding symptom, an option that simply reads more confident than the rest — substitute for the actual reasoning underneath it. The Rotterdam criteria's any-two-of-three structure, PALM-COEIN's structural/non-structural split, and the unopposed-oestrogen mechanism threading through AUB, PCOS, and endometrial cancer alike are exactly the kind of connective tissue examiners test directly. If any case seems clinically off-pitch, pitched at the wrong level for the examination, or missing a nuance that matters in practice, the contact page is open. Good feedback sharpens every subsequent round.
Summative Revision Notes
A companion revision file covers all seven topics in condensed form — key tables, thresholds, the PALM-COEIN and Rotterdam frameworks, eponymous signs, number anchors, and sequence rules — designed for rapid pre-exam consolidation rather than first-time learning. Open Revision Notes →
Morning Rounds · atsixty.com · Seven rounds · 35 high-yield clinical cases · +4 / −1 scoring · NEET-PG